Showing results (1-10 of 182) with videos related to
Sort By:
Pageof 19
Cell Metabolism|November 15, 2016
Immunotherapy for Type 1 Diabetes: Why Do Current Protocols Not Halt the Underlying Disease Process?Hubert Kolb, Matthias von HerrathDiabetes|December 31, 2008
Can we learn from viruses how to prevent type 1 diabetes?: the role of viral infections in the pathogenesis of type 1 diabetes and the development of novel combination therapiesMatthias von HerrathCurrent Opinion in Investigational Drugs (London, England : 2000)|November 2, 2005
E1-INT (Transition Therapeutics/Novo Nordisk)Matthias von HerrathHuman Vaccines|December 16, 2010
Type 1 diabetes vaccine development: animal models vs. humansTobias Boettler, Matthias von HerrathInternational Immunopharmacology|July 30, 2010
Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1DTobias Boettler, Matthias von HerrathPediatric Diabetes|December 17, 2004
Islet regeneration needed for overcoming autoimmune destruction - considerations on the pathogenesis of type 1 diabetesMatthias von Herrath, Dirk HomannExpert Review of Clinical Immunology|May 19, 2010
Immunoinformatics: an overview of computational tools and techniques for understanding immune functionMatthias von Herrath, Paul TaylorActa Diabetologica|December 1, 2017
The shifting paradigm of a "cure" for type 1 diabetes: is technology replacing immune-based therapies?Jeremy Pettus, Matthias Von HerrathTrends in Immunology|October 14, 2003
Introducing baselines for therapeutic use of regulatory T cells and cytokines in autoimmunityMatthias von Herrath, Dirk HomannTrends in Immunology|May 19, 2019
Regulatory Immune Mechanisms beyond Regulatory T CellsGustaf Christoffersson, Matthias von HerrathPageof 19